Anzeige
Mehr »
Login
Samstag, 13.04.2024 Börsentäglich über 12.000 News von 689 internationalen Medien
Spezial: Montag letzte Chance vor großer Verkündung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2N5RY | ISIN: US40131M1099 | Ticker-Symbol: 5GH
Tradegate
12.04.24
18:09 Uhr
17,250 Euro
+0,060
+0,35 %
1-Jahres-Chart
GUARDANT HEALTH INC Chart 1 Jahr
5-Tage-Chart
GUARDANT HEALTH INC 5-Tage-Chart
RealtimeGeldBriefZeit
16,90017,32013:04
16,94517,43012.04.

Aktuelle News zur GUARDANT HEALTH Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
05.04.Analyst Expectations For Guardant Health's Future4
22.03.Guardant Health, Inc. - 8-K, Current Report2
14.03.Exact, Guardant tout successes of next-gen colorectal cancer screeners7
04.03.Guardant Health exposes colorectal cancer screening gap with new Harris Poll report3
23.02.Guardant Health, Inc. - S-8, Securities to be offered to employees in employee benefit plans1
23.02.Guardant Health hits 52-week low after in-line guidance4
23.02.Cancer Test Focused Guardant Health Stock Falls On FDA AdCom Update For Colorectal Test7
23.02.Guardant Health Inc reports results for the quarter ended in December - Earnings Summary1
23.02.Earnings call: Guardant Health sees 22% revenue growth in Q4 20233
22.02.Guardant Health, Inc. - 10-K, Annual Report2
22.02.Guardant Health Non-GAAP EPS of -$0.64 beats by $0.11, revenue of $155.1M beats by $4.31M4
22.02.Guardant Health: Q4 Earnings Insights2
22.02.Guardant Health, Inc. - 8-K, Current Report-
22.02.Guardant Health Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Outlook140PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today reported financial results for the quarter and full year ended December 31, 2023. Fourth...
► Artikel lesen
01.02.Guardant Health, Inc. - 8-K, Current Report4
30.01.Decoding 4 Analyst Evaluations For Guardant Health7
08.01.Guardant Health, Inc. - 8-K, Current Report1
08.01.Guardant Health forecasts upbeat Q4, 2023 revenue guidance5
08.01.Guardant Health Announces Preliminary Fourth Quarter and Full Year 2023 Results167PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced preliminary, unaudited results for the quarter and full year ended...
► Artikel lesen
08.01.Guardant Health, Hikma To Offer Cancer Screening & Genomic Profiling Tests In Middle East & Africa387LONDON (dpa-AFX) - Guardant Health Inc. (GH) and Hikma Pharmaceuticals have entered into an agreement to collaborate on the promotion of Guardant Health's range of liquid and tissue biopsy tests....
► Artikel lesen
Seite:  Weiter >>
49 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1